Elze Christian 4
4 · Protalix BioTherapeutics, Inc. · Filed Sep 4, 2025
Insider Transaction Report
Form 4
Elze Christian
Director
Transactions
- Award
Stock Options (Right to Buy)
2025-09-03+15,000→ 15,000 totalExercise: $1.64Exp: 2035-09-03→ Common Stock (15,000 underlying) - Award
Common Stock
2025-09-03+7,500→ 7,500 total(indirect: By Trust)
Footnotes (3)
- [F1]Represents restricted shares of common stock awarded to the Reporting Person under the Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan, as amended (the "Plan"). The restricted shares vest in 12 equal quarterly installments commencing upon the date of grant.
- [F2]To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued under the Plan must be registered in the name of a trustee.
- [F3]The shares of common stock underlying the stock options shall vest in 12 equal quarterly installments commencing upon the date of grant.